Purpose:Several recent open studies have provided encouraging results as to the e cacy of intravesical installations of capsaicin for neurogenic hyperre¯ectivity. The present trial was performed to verify these results under controlled conditions. Intravesical installation of capsaicin represents a new therapeutic hope for the treatment of the neurogenic hyperrelfexic bladder. Method: This randomized, double-blind study compared the results of the intravesical installation of 30 mg capsaicin in 100 ml of 30% alcohol (experimental group) with those of installing 100 ml 30% alcohol alone (control group). On day 0 and day 30, urodynamic and biopsic examinations were performed in all subjects of each group. Patients: All the subjects included in the study had a functionally disabling form of neurogenic hyperre¯exic bladder resistant to the usual therapies. Cystoscopy and retrograde cystography were performed to exclude any patient who presented with a tumor-like lesion or had vesicoureteral re¯ux. Results: Twelve paraplegic of tetraplegic subjects, seven women and ®ve men whose average age was 46, were included. Eight had multiple sclerosis, and four had sustained a traumatic spinal cord injury. The patients were randomly separated into two groups of six. Initially, there was no clinical or urodynamic di erences in these groups. Installation immediately triggered side e ects and during the ®rst 7 days (suprapubic burning sensation, sensory urgency, hot¯ushes, autonomic hyperre¯exia, hematuria) in ®ve of the six subjects in both groups. Bladder biopsy revealed no signi®cant deterioration. On day 30, there was improvement in all of the experimental-group of patients with signi®cant regression of leakage (P=0.002) and of sensory urgency (P=0.01). Only one control subject had amelioration. Urodynamic examination showed a rise in bladder capacity from 172.5 to 312.3 ml in the experimental group, signi®cantly greater (P=0.03) than the rise from 129 to 175.3 ml observed in the control group. Conclusion: This trial fully con®rms the e cacy of intravesical installations of capsaicin, an e cacy obtained at the cost of nonnegligible side e ects. An intermediate-term follow-up of this treatment will be necessary before considering more widespread use of this agent.